Ryman Healthcare is offering retail shareholders the opportunity to participate in a 1 for 2.81 accelerated pro rata entitlement offer of new ordinary shares, which will raise $902 million.
This offer gives eligible retail shareholders the right to purchase new shares at a 17.1% discount to the theoretical ex-rights price.
The funds raised will be used to reset Ryman’s capital structure, strengthen its balance sheet and better enable the company to execute its growth framework.
The retail component of the offer opened today and will close on 6 March.
See more
